*Refresh the page if the below document does not appear.
World Health Organisation (WHO) raised an alarm over the use of four cough syrups made by an Indian company after the alleged death of 66 children in the Gambia. It is now conducting investigation with the Haryana-based company and the regulatory authorities.
Sumitovant Biopharma has 52% of outstanding shares in Myovant and they posposed to acquire the remaining shares for $22.75 per share in cash. After announcing the rejection of the offer, Myovant reasoned that the proposed bid “significantly undervalues” them.
The US Apex Court refused to hear Biogen Inc’s request to win a reinstatement of the patent for their megahit drug Tecfidera indicated for multiple sclerosis, giving Viatris Inc subsidiary (VTRS.O) Mylan Pharmaceuticals Inc. the right to move forward with the generic version of the drug.
The Mumbai-based Pharmaceutical Company claims that they are in the final stages of development of an eye formulation that can change the lives of millions of elderly people suffering from Presbiopia. The clinical trials have shown positive results worldwide including the US.
Unichem Pharmaceuticals US Inc has decided to recall 18960 bottles of its hypertension drug Clonidine Hydrochloride from the US Market. As per the regulatory authority, 0.2 mg strength Tablets, USP were found in a 100-count bottle of 0.3 mg strength tablets.
The Biopharmaceutical Company Ventus Therapeutics, Inc. has entered into an exclusive worldwide license agreement with Novo Nordisk A/S to work on the the development and marketing of peripherally-restricted NLRP3 inhibitors for which it holds the rights.
The US regulatory body has granted ODD
(Orphan Drug Designation) to the Clinical
Stage Biopharmaceutical Company, Poxel SA
for its novel first-in-class drug PXL770 which
will be used to treat patients suffering from
autosomal-dominant polycystic kidney
disease (ADPKD).
Please update your profile to keep using the website